home / stock / pti / pti news

PTI News and Press, Yumanity Therapeutics Inc Com From 10/21/19

Stock Information
Company Name: Yumanity Therapeutics Inc Com
Stock Symbol: PTI
Market: NASDAQ
Menu
PTI PTI Quote PTI Short PTI News PTI Articles PTI Message Board
Get PTI Alerts

News, Short Squeeze, Breakout and More Instantly...
PTI - Proteostasis Therapeutics to Host Cystic Fibrosis Summit on Disparity in Access to CFTR Modulators Based on Geography Featuring Members of the Cystic Fibrosis Community and Thought Leaders

BOSTON , Oct. 21, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processin...
PTI - Boehringer Ingelheim launches mid-stage study of new CF treatment

Privately held Boehringer Ingelheim announces the start of enrollment in a Phase 2 clinical trial evaluating different doses of BI 1265162, an epithelial sodium channel inhibitor delivered via the Respimat inhaler, in cystic fibrosis (CF) patients regardless of their mutation status. M...

PTI - Proteostasis Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

BOSTON , Sept. 26, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processi...

PTI - Proteostasis Therapeutics Announces Presentation at the UK Cystic Fibrosis Conference

BOSTON , Sept.19, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein proce...
PTI - Proteostasis Therapeutics reports Q2 results

Proteostasis Therapeutics (NASDAQ: PTI ): Q2 GAAP EPS of -$0.39. More news on: Proteostasis Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

PTI - Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update

BOSTON , Aug. 7, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processin...

PTI - Dosing underway in mid-stage CF study of Proteostasis combo therapies

The first patient has been dosed in a Phase 2 clinical trial evaluating Proteostasis Therapeutics' ( PTI -1.6% ) doublet therapy (PTI-808 and PTI-801) and triplet therapy (doublet + PTI-428) in up to 30 F508del homozygous cystic fibrosis (CF) patients and up to 30 F508del heterozygous ...
PTI - Proteostasis Therapeutics Initiates Dosing in Global Phase 2 Study in Cystic Fibrosis

BOSTON , July 25, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced that the first patient has been dosed in t...

PTI - Proteostasis Therapeutics Announces Management Changes and Appointments

BOSTON , July 23, 2019 /PRNewswire/ -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein ...

PTI - PVTL and IFRX among premarket losers

InflaRx N.V. (NASDAQ: IFRX )  -87%  after IFX-1 flunks mid-stage study. More news on: InflaRx N.V., GameStop Corp., ChemoCentryx, Inc., Stocks on the move, Read more ...

Previous 10 Next 10